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Abstract
Varicella zoster virus causes two distinct clinical diseases. Varicella is the primary infection and results
from exposure of a person susceptible to the virus. The virus remains latent in cranial nerve ganglia,
dorsal root ganglia, and autonomic ganglia along the entire neuraxis. Years later, in association with a
decline in cell-mediated immunity in the elderly and immuno-compromised, varicella zoster virus
reactivates and can cause a wide range of neurologic disease, including herpes zoster (‘shingles’),
postherpetic neuralgia, vasculopathy, myelopathy, retinal necrosis, cerebellitis, and zoster sine
herpete. Herpes zoster is associated with numerous neurologic complications and varied
presentations. Patients who have a dermatomal distribution of varicella zoster virus and who have
headaches should be considered to have VZV meningitis. Virologic confirmation requires testing
the cerebrospinal fluid for varicella zoster virus deoxyribonucleic acid via polymerase chain
reaction. The application of polymerase chain reaction to the cerebrospinal fluid can be used to
detect varicella zoster virus deoxyribonucleic acid and, therefore, infections of the central nervous
system. We present a case report of a 46-year-old female who initially presented with worsening
headache, nuchal rigidity, fever, and a skin rash, who was subsequently found to have varicella zoster
meningitis.
Case presentation
A 46-year-old Caucasian female of Irish-American descent
presented to the emergency department (ED) with a one-
day history of worsening headache, nuchal rigidity, and
fever. She also complained of photophobia, nausea, one
episode of vomiting, and backache.
The patient’s past medical history was significant for
nephrolithiasis. The patient denied any medications at
home or allergies. She denied any family history of heart
disease, cancer, or hypertension. The patient denied
smoking, alcohol use, or intravenous drug use. Immuniza-
tions were up to date.
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months prior to admission. She spent a significant time
outdoors and swimming. She denied insect bites.
Since the past ten days, she had experienced significant
pain under her left breast, 7/10 pain scale, with a vesicular
eruption occurring for three days.
Review of systems was notable for headache, neck
stiffness, the vesicular skin rash and fever.
Vital signs in the ED were noted to be: blood pressure =
150/83 mmHg, temperature = 101°F, respirations = 18
breaths per minute, and pulse = 87 beats per minute.
Patient was awake, alert, and oriented to person, place,
and time. Physical exam revealed a unilateral vesicular
rash extending from T8-T9 dermatomal pattern to under
the left breast. Nuchal rigidity was noted. Heart, lung, and
abdominal exams were within normal limits.
Upon admission, the patient had a WBC count of
5.2 × 10
3 cells/ µL with normal chemistries.
Computed tomography scan of the head showed no
evidence of acute infarct, hemorrhage, or mass effect. A
lumbar puncture was done and the patient was started
empirically on intravenous ceftriaxone and vancomycin,
oral acyclovir, and dexamethosone. The cerebrospinal
fluid (CSF) was also sent to the department of health for
Lyme IgM / IgG antibodies, West Nile Virus IgM / IgG,
Herpes Simplex Virus 1, 2 DNA PCR and Varicella Zoster
Virus (VZV) DNA.
The CSF was noted to be clear / colorless and contained
10 RBCs/mm
3, 127 WBCs/mm
3 (100% lymphocytes),
glucose 49 mg/dL (serum level, 130), protein 125 mg/dL.
The CSF gram stain showed no organisms, with a
negative India ink stain and negative CSF bacterial
cultures. Acyclovir was continued and antibiotics were
stopped.
The initial blood cultures were negative for growth.
Serologies for ehrlichia and babesia antibodies were
negative. Cerebrospinal fluid testing for Borrelia, WNV,
and HSV 1 and 2 were also negative.
By the third day of hospitalization, the patient reported
feeling markedly better with reduced headache, neck
stiffness and was afebrile. The vesicular rash still persisted
and now was associated with pain.
On the fifth day of hospitalization, the patient continued
to improve and prednisone was discontinued. The next
day, the patient was discharged on a course of oral
acyclovir.
Several days after the patient was discharged, the depart-
ment of health reported that the patient’s CSF was positive
for VZV DNA. The patient was contacted at home. She
reported to be in good health and denied further
meningeal signs and fever.
Discussion
Varicella zoster virus (VZV) causes two distinct clinical
diseases. Varicella, is the primary infection and results
from exposure of a person susceptible to the virus. The
virus remains latent in cranial nerve ganglia, dorsal
root ganglia, and autonomic ganglia along the entire
neuraxis. Years later, in association with a decline in cell-
mediated immunity in the elderly and immunocompro-
mised, VZV reactivates and can cause a wide range of
neurologic disease, including herpes zoster, postherpetic
neuralgia, vasculopathy, myelopathy, retinal necrosis,
cerebellitis, and zoster sine herpete [1]. Although varicella
is mainly a childhood disease, VZV is associated with
serious complications, such as CNS involvement, pneu-
monia, secondary bacterial infections, and death [2].
Older age, immunocompromised state, and possibly
pregnancy are risk factors associated with higher severity
of varicella [3]. The danger of dying from varicella is
highest in infants and in elderly individuals. Although
varicella is more severe in immunocompromised persons,
most cases of severe morbidity and mortality are seen in
healthy people [4].
Most patients are over 60 or immunocompromised [5].
Bone marrow transplant recipients and HIV-positive
patients are at particular risk. Not surprisingly, zoster in
otherwise young, healthy individuals may be the first
manifestation of HIV infection [6].
Extracutaneous sites of involvement include the central
nervous system (CNS), as manifested by meningo-
encephalitis or encephalitis. The clinical presentation is
similar to other viral infections of the brain. Several studies
conducted in patients with herpes zoster have demon-
strated that subclincal meningeal irritation, indicated by
a reactive CSF pleocytosis can occur in many cases [7].
Herpes zoster can be associated with subtle signs of aseptic
meningitis - mild CSF mononuclear pleocytosis with slight
increase in protein levels - in up to 50% of patients. The
application of PCR to the CSF can be used to detect VZV
DNA and, therefore, infections of the CNS. The opportu-
nity to study the characteristics of different viral infections
of the CNS has been aided by viral PCR of CSF. While CSF
protein levels greater than 1000 mg/dL are considered
unusual in viral meningitis, in a recent retrospective study,
patients with VZV CNS infection had significantly higher
CSF protein levels (median > 974 mg/dL) than did
patients with enteroviral CNS infection [8] A rare
manifestation of CNS involvement by herpes zoster is
Page 2 of 4
(page number not for citation purposes)
Cases Journal 2009, 2:6299 http://casesjournal.com/casesjournal/article/view/6299granulomatous cerebral angiitis, which usually follows
zoster ophthalmicus [9].
Acute inflammatory demyelinating polyneuropathy
(AIDP, or Guillain-Barre syndrome) is also a rare
neurologic complication of varicella and herpes zoster
[10]. Patients can have symptoms that are similar to other
AIDP that follow other infections.
Myelitis is a common complication following herpes
zoster and is sometimes referred to as “postinfectious
myelitis”. Spinal cord involvement can occur in almost
50% of patients with spinal (cervical, thoracic, and
lumbosacral) herpes zoster [11]. Patients can present
with paraparesis, impaired sensation with a level compa-
tible with the segment of VZV reactivation, and sphincter
dysfunction. Nevertheless, in the majority of patients, the
involvement of the spinal cord is subtle and asympto-
matic, and complete recovery is usually achieved.
Another form of VZV myelitis has come to be associated
with AIDS patients and is often insidious, progressive, and
sometimes fatal. Myeltis in HIV-infected patients involves
the spread of VZV from the dorsal root ganglia centrally
into the spinal cord parenchyma. CSF exam reveals
findings typical of viral encephalitis. Magnetic resonance
imaging (MRI) can show longitudinal, serpiginous enhan-
cing lesions. Diagnosis is confirmed with the presence of
VZV DNA in the CSF via PCR. Several reports describe
zoster myelitis in HIV-infected patients in the absence of
any rash and have documented VZV DNA within spinal
cord specimens at autopsy [12]
Large vessel granulomatous arteritis is usually a disorder of
immunocompetent individuals and can follow herpes
zoster or varicella [13]. It is mainly a disorder of the elderly
where a brain infarction develops weeks to months
following ipsilateral trigeminal zoster and is associated
with a mortality of up to 25% [14]. Cerebral aneurysms
and hemorrhage can also develop from viral invasion of
the vessels. The CSF can show mild lymphocytic pleocy-
tosis, increased protein, sometimes oligoclonal bands, and
PCR is positive for VZV nucleic acid. In cases of VZV
vasculopathy, the CSF does not always contain PCR-
amplifiable VZV DNA, but does contain anti-VZV IgG [15].
Because of the high mortality rate, testing via PCR for both
VZV DNA and anti-VZV IgG should be done. Angiography
reveals focal narrowing or occlusion of the blood vessel
which on autopsy displays arterial inflammation with
multinucleated giant cells, Cowdry type A inclusion
bodies, and VZV nucleic acid [16].
Small vessel multifocal vasculopathy usually occurs in
immunocompromised patients. It usually occurs without
any skin lesions and consists of subacute multifocal
neurological deficits along with headache, fever, mental
status changes, and seizures [17]. A history of herpes zoster
may precede the symptomatology by several weeks to
months. Cerebrospinal fluid analysis is similar to that of
large vessel granulomatous arteritis. The MRI typically
demonstrates multifocal infarcts and autopsy reveals
mixed necrotic and demyelinative lesions with small
vessel vasculopathy.
Focal motor weakness is another neurologic complication
that may follow herpes zoster. Motor impairment may
follow herpes zoster anywhere from one day to several
months and usually involves the same segment that was
affected by the rash. Arm weakness and diaphragmatic
paresis has been associated with herpes zoster in the
cervical dermatomes [18]. Lumbosacral herpes zoster has
been associated with leg weakness. Neurogenic bladder
and loss of anal sphincter control can follow sacral herpes
zoster [19]. Peripheral facial weakness has been reported
with herpes zoster oticus. The prognosis of focal motor
weakness is generally fair with more than half of patients
regaining full motor power [20].
In our patient, the argument can be made that the
acyclovir could have been given intravenously. However,
a common bedside challenge is to determine whether a
case of meningitis has a bacterial or viral etiology, as this
will effect antimicrobial selection, which in turn, has its
risks and benefits. Seriously ill patients with suspected
viral meningitis should probably receive intravenous
antiviral therapy. Oral acyclovir can be tried on less
severely ill patients, although data on efficacy are lacking.
Oral acyclovir was chosen in our patient as she was
hemodynamically stable and did not have focal neurolo-
gical deficits.
Also, in our patient, the CSF glucose/serum glucose
ratio was low. Glucose in the CSF normally approx-
imates 60% of the serum glucose level. Low CSF glucose
is often seen with bacterial meningitis and is also one
of the hallmarks of meningealc a r c i n o m a t o s i sa sw e l l
as CNS sarcoidosis. The CSF glucose level is typically
normal during viral infections. However, low CSF
glucose levels can occasionally be observed with
mumps, enteroviruses, lymphocytic choriomeningitis,
as well as herpes simplex and varicella zoster viruses
[ 2 1 ] .T h i sa s p e c to fo u rc a s em a k e si ta t y p i c a lo fm o s t
cases of VZV meningitis.
In conclusion, herpes zoster is associated with a wide
range of neurologic complications and presentations.
Patients who have a dermatomal distribution of VZV
and who have headaches should be considered to have
VZV meningitis. Virologic confirmation requires testing
the CSF for VZV DNA via PCR.
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